9-Aminoacridine inhibits ribosome biogenesis and synergizes with cytotoxic drugs to induce selective killing of p53-deficient cells.

被引：0
|
作者：
Anikin, L. [1 ,2 ]
Pestov, D. [1 ]
机构：
[1] Rowan Univ, Sch Osteopath Med, Cell Biol Neurosci, Stratford, NJ USA
[2] Rowan Univ, Grad Sch Biomed Sci, Stratford, NJ USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P2170
引用
收藏
页数：2
相关论文
共 11 条
  • [1] Selective killing of p53-deficient cancer cells by SP600125
    Jemaa, Mohamed
    Vitale, Ilio
    Kepp, Oliver
    Berardinelli, Francesco
    Galluzzi, Lorenzo
    Senovilla, Laura
    Marino, Guillermo
    Malik, Shoaib Ahmad
    Rello-Varona, Santiago
    Lissa, Delphine
    Antoccia, Antonio
    Tailler, Maximilien
    Schlemmer, Frederic
    Harper, Francis
    Pierron, Gerard
    Castedo, Maria
    Kroemer, Guido
    EMBO MOLECULAR MEDICINE, 2012, 4 (06) : 500 - 514
  • [2] Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
    Reaper, Philip M.
    Griffiths, Matthew R.
    Long, Joanna M.
    Charrier, Jean-Damien
    MacCormick, Somhairle
    Charlton, Peter A.
    Golec, Julian M. C.
    Pollard, John R.
    NATURE CHEMICAL BIOLOGY, 2011, 7 (07) : 428 - 430
  • [3] Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
    Reaper P.M.
    Griffiths M.R.
    Long J.M.
    Charrier J.-D.
    MacCormick S.
    Charlton P.A.
    Golec J.M.C.
    Pollard J.R.
    Nature Chemical Biology, 2011, 7 (7) : 428 - 430
  • [4] Self-deleting suicide vectors (SDSV):: Selective killing of p53-deficient cancer cells
    Andreú, T
    Ebensperger, C
    Westphal, EM
    Klenner, T
    Stewart, AF
    Westhof, A
    Müller, P
    Knaus, R
    von Melchner, H
    CANCER GENE THERAPY, 2000, 7 (12) : S9 - S10
  • [5] Self-deleting suicide vectors (SDSV):: Selective killing of p53-deficient cancer cells
    Andreú, T
    Ebensperger, C
    Westphal, EM
    Klenner, T
    Stewart, AF
    Westhof, A
    Müller, P
    Knaus, R
    von Melchner, H
    CANCER RESEARCH, 2001, 61 (18) : 6925 - 6930
  • [6] Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs
    Mikhail V Blagosklonny
    Oncogene, 2002, 21 : 6249 - 6254
  • [7] Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs
    Blagosklonny, MV
    ONCOGENE, 2002, 21 (41) : 6249 - 6254
  • [8] Synthesizing a Genetic Sensor Based on CRISPR-Cas9 for Specifically Killing p53-Deficient Cancer Cells
    Zhan, Hengji
    Xie, Haibiao
    Zhou, Qun
    Liu, Yuchen
    Huang, Weiren
    ACS SYNTHETIC BIOLOGY, 2018, 7 (07): : 1798 - 1807
  • [9] Raphanus sativus Sprout Causes Selective Cytotoxic Effect on p53-Deficient Human Lung Cancer Cells in vitro
    Baek, Jiwon
    Roh, Hyun-Soo
    Choi, Chang-Ik
    Baek, Kwan-Hyuck
    Kim, Ki Hyun
    NATURAL PRODUCT COMMUNICATIONS, 2017, 12 (02) : 237 - 240
  • [10] Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs
    Roudier, Emilie
    Mistafa, Oras
    Stenius, Ulla
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (11) : 2706 - 2715
12